Physician

Mary Kara Bucci, MD

According to 2025 Medicare claims, Mary Bucci, MD (NPI: 1285727883) practices radiation oncology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (NPI: 1164475232; TIN: 850367056) and primary practice location at 87109-4495. Bucci is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Bucci's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 238 traditional Medicare patients, billed 4,081 HCPCS/CPT codes, and received $523,362 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 175 prescription claims across 92 beneficiaries totaling $3,197 in drug costs, led by Mometasone Furoate (Mometasone Furoate). Open Payments data shows 5 records totaling $290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $51,688 to $523,362. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $888 and ending at $3,197. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.